Sudarshan Pharma shares surged nearly 4% to ₹20.25 following the company's announcement of Q3FY26 results. The pharmaceutical company reported revenue of ₹168 crore in Q3FY26, up from ₹115 crore in Q3FY25, marking a 37% year-on-year growth. For the nine months ended December 31, 2025 (9MFY26), revenue rose to ₹467.69 crore from ₹340.93 crore in 9MFY25, reflecting a strong 37% increase. The company's EBITDA for Q3FY26 stood at approximately ₹10.87 crore, compared to ₹7.97 crore in Q3FY25. For 9MFY26, EBITDA was around ₹31 crore, up from ₹23 crore in the same period last year. On the bottom line, the company reported a net profit of ₹4.15 crore, up from ₹2.88 crore in Q3FY25, indicating a 44% YoY increase. For 9MFY26, net profit rose to ₹12 crore from ₹7.55 crore in the same period last year, a 56% increase, reflecting both revenue growth and improved operational efficiency.
The company's shares have come under sharp selling pressure in January, building on heavy losses in 2025. So far this month, the stock has declined 27.40%, marking its biggest monthly drop since February 2025. Earlier this month, it also touched its lowest level since September 2024. Despite this short-term weakness, the stock ended 2025 with a steep fall of 38.21%. However, the long-term performance remains strong, with gains of 165% from earlier levels. The company is engaged in manufacturing of APl, Jobwork manufacturing in pharmaceuticals items and trading in chemicals and solvents in India, focusing on speciality chemicals with a business model that offers end-to-end manufacturing within a single Special Economic Zone (SEZ).
Sudarshan Pharma is engaged in manufacturing of APl, Jobwork manufacturing in pharmaceuticals items and trading in chemicals and solvents in India. The company is engaged in the business of speciality chemicals, focusing on pharmaceutical manufacturing and chemical trading operations. The company's strong export contribution, accounting for 90% of revenues, underscores robust traction with global Original Equipment Manufacturers (OEMs).
